Metronomia Clinical Research

What Metronomia Clinical Research does

Metronomia Clinical Research GmbH (METRONOMIA) is a privately held, Munich-headquartered Contract Research Organization founded in 1990 that specializes exclusively in clinical trial biometrics and data science. Its service portfolio comprises four core lines: biostatistical consulting, biostatistical services (including statistical programming and CDISC-compliant SDTM/ADaM outputs), clinical data management (including EDC deployment, data cleaning, and database lock), and medical writing (clinical study reports and regulatory submissions). Complementary offerings include Independent Data Monitoring Committee (IDMC) support, non-clinical/preclinical statistical services, and a clinical data rescue service for underperforming studies. The underlying technology stack combines proprietary assets, including a Clinical Data Warehouse, an in-house IWRS for central randomization and medication logistics, and a scanTrace system for paper CRF capture, with third-party platforms, notably Medidata Rave EDC, in which METRONOMIA is an accredited partner. The company holds CDISC Gold Membership and operates a 24/7 global EDC service desk.

METRONOMIA serves pharmaceutical, biotech, and medical device sponsors globally, with documented operational reach spanning Germany (Munich headquarters), the United States (Boston opened 2023, Durham, NC opened 2025), and South Africa (Bloemfontein opened 2024). The company has executed more than 720 projects across all clinical phases, including more than 175 oncology studies and a 15-year engagement supporting an antibody therapy for acute lymphoblastic leukemia that achieved accelerated FDA BLA approval in 2014. Its client base reports a greater than 92% repeat business rate. The team comprises more than 160 experts drawn from more than 20 nationalities, including statisticians, data managers, clinical programmers, and medical writers. Leadership consists of three Managing Directors: Markus Niemeier, Dr. Simon Rückinger, and founder Rudolf Köhne-Volland, who have jointly led the company since November 2022.

The business model is professional services-based: METRONOMIA delivers biometrics engagements under project-based contracts, with pricing customized per engagement and not publicly disclosed. Revenue is generated through consulting fees and FTE-based study work spanning all clinical development phases (I-IV) and major therapeutic areas including oncology, dermatology, immunology, and rare diseases. Go-to-market is enterprise field sales, anchored by Business Development Directors who engage pharmaceutical and biotech decision-makers directly, supplemented by active participation in industry conferences (BIO-Europe, OCT events, ACDM, ESMO, Medidata NEXT, DIA, and others) and an RFI submission channel on the company website. METRONOMIA is independently owned, has never disclosed external venture or private equity funding, and operates without a parent company. Compliance credentials include ISO 27001:2022 certification, GDPR and German BDSG adherence, clean FDA (2014) and EMA/BfArM (2013) inspections, and membership in the German CRO association BVMA.

Name

Metronomia Clinical Research

Legal name

METRONOMIA Clinical Research GmbH

Website

https://metronomia.net

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

101–250 employees

Short description

Metronomia Clinical Research is a privately held Munich-based biometrics-focused CRO founded in 1990, providing biostatistical consulting, biostatistical services, clinical data management, and medical writing to pharmaceutical, biotech, and medical device sponsors globally, with 160+ specialists and 720+ completed projects.

Ownership category

akta.pro rank

Product category

Clinical Research Services (CRO Biometrics)

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

akta.pro secondary industries

Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical research services
• Biostatistical consulting
• Clinical data management
• Medical writing services
• Contract research organization

Headquarters

HQ city

München

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Biostatistical Consulting Services: Expert statistical consulting services for clinical trial design, protocol development, statistical analysis planning, and regulatory submissions. Billed on a project basis as part of full-service CRO engagements.
2. Biostatistical Services: Statistical programming and analysis services including SDTM and ADaM data standards, CDISC-compliant outputs. Revenue generated through project-based contracts.
3. Clinical Data Management: End-to-end clinical data management services including EDC system deployment, data cleaning, medical coding, and database lock. Delivered as professional services under contract.
4. Medical Writing: Medical writing services including clinical study reports, regulatory submissions, and documentation. Provided as part of integrated CRO service offerings.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

Metronomia Clinical Research is a specialized mid-size European Contract Research Organization (CRO) providing biometrics and clinical data science services to pharmaceutical, biotech, and medical device companies. Its core offerings are biostatistical consulting, biostatistical services (statistical programming and analysis), clinical data management (EDC deployment, data cleaning, database lock), and medical writing (study reports, regulatory submissions). The company delivers these services across all clinical development phases (Phase I-IV), non-interventional studies, and major therapeutic areas including oncology, dermatology, immunology, and rare diseases.

Product overview

Metronomia Clinical Research is a specialized CRO (Contract Research Organization) providing a unified suite of biometrics and data science services for clinical trials. The core offerings include Biostatistical Consulting, Biostatistical Services, Clinical Data Management, Medical Writing, IDMC Support Services, and Non-Clinical Support. These services are delivered by a team of over 150 experts across offices in Germany (Munich headquarters), USA (Durham, NC and Boston), and South Africa (Bloemfontein). The company serves pharmaceutical, biotech, and medical device companies with over 720 successful projects spanning all clinical development phases.

Differentiator

Problem solved

Functional benefit

Products and services

• Biostatistical Consulting Expert statistical consulting services for clinical trial design, protocol development, statistical analysis planning, and regulatory strategy. Delivered to pharmaceutical, biotech, and medical device sponsors.
• Biostatistical Services Statistical programming, data analysis, and statistical reporting services for clinical development programs, including SDTM and ADaM CDISC-compliant outputs. Billed on a project basis as part of full-service CRO engagements.
• Clinical Data Management End-to-end clinical data management services including EDC system deployment, data cleaning, medical coding, and database lock. Delivered as professional services under contract.
• Medical Writing Professional medical writing services for clinical study reports, regulatory submissions, scientific publications, and clinical trial documentation.
• IDMC Support Services Independent Data Monitoring Committee (IDMC) support services for clinical trials, providing statistical and operational support to data monitoring committees reviewing trial safety and efficacy data.
• Non-Clinical Support Data science and statistical support for non-clinical and preclinical research studies, extending Metronomia's biometrics expertise beyond human clinical trials.
• Rescue Services Clinical data management and statistical rescue services for underperforming studies, including takeover from deficient CROs and turnaround of distressed clinical programs in oncology and dermatology.

Quantifiable outcome

• >92% repeat business rate demonstrating exceptional client retention
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability1 record

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• MedidatacoreTechnology or Integration · 29 November 2024METRONOMIA is an accredited Medidata partner deploying Medidata Rave EDC platform for customers. The partnership enables delivery of advanced, robust and secure electronic data capture. The collaboration empowers METRONOMIA to support biotech and pharmaceutical innovators under tight timelines and resource constraints, helping clients mitigate risks and optimize clinical trial outcomes.
• DVMD (Fachverband für Dokumentation und Informationsmanagement in der Medizin)minorOthers · 1 January 2019METRONOMIA is an active DVMD member, participating in the annual DVMD congress and co-organizing the 3rd Frühjahrssymposium in 2020. DVMD connects professionals in clinical documentation and data management in Germany.
• CDISC (Gold Member)coreTechnology or Integration · 1 January 2015METRONOMIA achieved CDISC Associate Member status in 2009 and upgraded to CDISC Gold Membership in 2019. As a Gold member, METRONOMIA demonstrates expert-level CDISC standards expertise for SDTM and ADaM implementation in clinical trials.
• BVMA (Bundesverband Medizinischer Auftragsinstitute)minorOthers · 1 January 2015METRONOMIA is a member of BVMA, the Federal Association of Contract Research Organisations in Germany. Membership since 2015 connects METRONOMIA with the German CRO industry network and regulatory developments.
• ZIFO TechnologiescoreTechnology or Integration · 1 January 2010Partnership established in 2010 with ZIFO Technologies (Chennai, India) for QC and SAS macro validation services. Collaboration expanded in 2012 to include statistical programming services and in 2015 to include EDC services.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Medpace: Mid-size US-headquartered CRO with strong focus on clinical trial management and biometrics. Highly comparable business model—specialized mid-tier CRO with similar therapeutic focus on oncology and Phase II/III work, and a track record of organic growth competing against larger incumbents.
• Rho: US-based mid-size CRO providing biostatistics, clinical data management, and regulatory services across multiple therapeutic areas. Directly comparable as a biometrics-focused mid-tier CRO serving pharma and biotech with similar scale and service mix.
• Worldwide Clinical Trials: Mid-size global CRO offering clinical trial services including biostatistics and data management. Comparable mid-tier positioning serving pharma/biotech across all phases, with similar personalized service model competing against large CROs.
• Premier Research: Mid-size global CRO with strong biometrics capabilities and focus on biotech/specialty pharma. Comparable in scale and service mix, particularly in oncology, rare disease, and pediatric therapeutic areas—directly competing for similar mid-size sponsor relationships.
• Celerion: Mid-size clinical research services provider focused on early-phase clinical pharmacology and biometrics. Comparable as a specialized mid-tier CRO with strong data sciences capabilities serving pharma/biotech in similar therapeutic and phase coverage.
• CATO Research (Cato SMS): Mid-size CRO offering regulatory, clinical, and biometrics services. Comparable in scale and as a specialized mid-tier alternative to large CROs, with overlapping capabilities in clinical data management and regulatory support.
• Clinipace Worldwide: Mid-size CRO with biometrics and clinical trial services across multiple therapeutic areas. Comparable mid-tier positioning with technology-enabled biometrics offering, competing for similar mid-size pharma and biotech engagements.

Broad incumbents

• IQVIA: World's largest CRO offering full-service clinical development including extensive biostatistics and data management capabilities. Comparable as a competitor with overlapping biometrics offerings, but operates at vastly larger scale and offers additional clinical monitoring and commercial services.
• ICON plc: Top-3 global full-service CRO with comprehensive biometrics, data management, and biostatistics capabilities. Comparable in biometrics service offerings but operates globally with substantially larger scale and broader service portfolio including labs and commercial services.
• Parexel: Large global full-service CRO with biostatistics and data management offerings across all phases. Comparable in core biometrics capabilities but substantially larger with broader service portfolio including regulatory consulting and clinical pharmacology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/metronomia-clinical-research-gmbh

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metronomia Clinical Research